general
Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy
Novai. a medtech company combatting blindness and disability by pioneering early detection and intervention for eye and brain diseases, today announced the publication of a peer-reviewed study in Expert Review of Ophthalmology, which successfully demonstrates its ‘Detection of Apoptosing Retinal Cells’ (DARC) imaging technology as a promising biomarker for identifying patients at high risk of central vision loss caused by macular atrophy (MA).
Novai. a medtech company combatting blindness and disability by pioneering early detection and intervention for eye and brain diseases, today announced the publication of a peer-reviewed study in Expert Review of Ophthalmology, which successfully dem... [3895 chars]
Read Full ArticleShare this story
Up next
Related Stories
NeuroScientific specialist hire sets stage for major Crohn’s trial
Sydney Morning Herald
Australian woman dies in Vietnam after cosmetic surgery: reports
Sydney Morning Herald
Climate activists banned from entering police ‘fort’ around Perth defence expo
Sydney Morning Herald
Federal Court rules against challenge to SA government's golf course plans
ABC News Australia
Australian couple among passengers on diverted flydubai flight to Israel, embassy says
The Guardian Australia